Martin Delaney Collaboratories for HIV Cure Research (UM1)
Post Date
May 21st 2015
Application Due Date
December 7th 2015
Funding Opportunity Number
RFA-AI-15-029
CFDA Number(s)
93.242
93.279
93.853
93.855
93.856
Funding Instrument Type(s)
Cooperative Agreement
Funding Activity Categories
Eligibility Categories
State Governments
County Governments
City or Township Governments
Special District Governments
Independent School Districts
Public and State Controlled Institutions of Higher Education
Federally Recognized Native American Tribal Governments
Public Housing Authorities or Indian Housing Authorities
Non-Federally Recognized Native American Tribal Organizations
Non-Profits With 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Non-Profits Without 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Private Institutions of Higher Education
For-Profit Organizations (Except Small Businesses)
Small Businesses
Other
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Funding
-
Award Range:
$None - $3500000
Grant Description
The purpose of this Funding Opportunity Announcement (FOA) is to address the problem of HIV persistence in HIV-infected persons treated with suppressive antiretroviral drug regimens.This FOA will support coordinated basic, translational, and clinical research focused on developing strategies to achieve an HIV cure, defined as sustained HIV remission and/or eradication.The application must include at least one private sector entity to facilitate rapid translation of basic discovery research into clinical studies.Collaboratory research should be milestone-based and centered on specific innovative approaches spanning characterization and quantification of latent or persistent HIV-1 reservoirs, identification of therapeutic strategies that target these reservoirs and/or control viral rebound, and preclinical and clinical studies to test new single or combination strategies for an HIV cure.
Contact Information
-
Agency
Department of Health and Human Services
-
Office:
National Institutes of Health
-
Agency Contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV -
Agency Mailing Address:
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
- Agency Email Address:
-
More Information:
http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-15-029.html
Get A Free Grant Assistance Kit
To start your application for a free grant package go to: